Myelodysplastic Syndromes (MDS) and Elderly Leukemia

Leukemia Cells

Cancer Site Specific Teams develop comprehensive quality cancer care service from screening to survivorship for patients with cancer. Dr. Suman Kambhampati is the director for the MDS and Elderly Leukemia Site Team, having clinics at both KU Cancer Center and the Kansas City Veteran's Medical Center, a research lab and is the primary investigator on multiple clinical trials.

Learn more about hematologic (blood) cancers:


Clinical Trials

There are many clinical trials at the University of Kansas Cancer Center. Please select the links below to learn more.

Contact our Clinical Trial Nurse Navigator:
Phone: 913-945-7552
Email: CTNurseNav@kumc.edu

Featured Trial:

Phase II Study to Evaluate Overall Response in Patients With Higher Risk Myelodysplastic Syndromes (MDS) Treated With Azacitidine With or Without Deferasirox

    • PI: Abdulraheem Yacoub, MD
    • NCT#: 02159040- To learn national information about this trial.

MDS/Elderly Leukemia Trials:


Support Groups

Last modified: Aug 06, 2015
Patient Story

Would you like to share a story about the treatment you or a loved one received at KU? Please contact Carol Webb at cwebb2@kumc.edu to enter your story.
• Read Susan's story

ID=x9067